Bigul

Metropolis Healthcare Ltd - 542650 - Intimation Of Certified True Copy Of Order Issued By Hon'Ble National Company Law Tribunal, Mumbai Bench With Respect To The Scheme Of Amalgamation And Arrangement Of Merger By Absorption

Intimation of Certified Copy of Order NCLT, Mumbai Bench under the provisions of sections 230 to 232 of the Companies Act, 2013 and other applicable provisions of the Act for sanctioning of the Scheme of Amalgamation and Arrangement of Merger by Absorption of M/s. Bokil Golwilkar Metropolis Healthcare Private Limited, M/s. Desai Metropolis Health Services Private Limited, M/s. Dr. Patel Metropolis Healthcare Private Limited, M/s. Lab One Metropolis Healthcare Services Private Limited, M/s. Micron Metropolis Healthcare Private Limited, M/s. R. V. Metropolis Diagnostic & Health Care Center Private Limited, M/s. Raj Metropolis Healthcare Private Limited and M/s. Sudharma Metropolis Health Services Private Limited ('Transferor Companies') with M/s. Metropolis Healthcare Limited ('Transferee Company/Company') and their respective Shareholders ('Scheme'), subject to receipt of applicable regulatory and other approvals.
07-07-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We herewith enclose the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended June 30, 2022 received from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company.
06-07-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

We are pleased to inform you that, the Company has received the Order of the Hon'ble National Company Law Tribunal, Mumbai Bench ('NCLT') on June 30, 2022, which was pronounced on June 02, 2022 sanctioning the Scheme. An uncertified copy of the said Order is made available on the NCLT website. The Order of the NCLT as uploaded on its website is attached for your record. The Company is awaiting for certified copy of the said order and once it is received, the company will inform to stock exchanges accordingly. The Scheme will become effective once the Certified Copy of the said order is filed by the respective companies with the Registrar of Companies
01-07-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Closure of Trading Window

This is to inform you that pursuant to the Company's Code of Fair Disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading window for dealing in securities of the Company by the Designated Persons of the Company and / or their immediate relatives will be closed with effect from July 01, 2022 and shall remain closed up to 48 (Forty Eight) hours after the declaration of the Financial Results of the Company for the quarter ended June 30, 2022. The date of the Board meeting for approval of financial results of the Company for the quarter ended June 30, 2022 shall be intimated in due course.
30-06-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir / Madam, Pursuant to the Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform that officials of the Company will be Meeting Investors (Participants) in the below conference: Date Conference Host Medium June 20, 2022 BNP Paribas Tele/Video Conferencing Kindly note that changes may happen due to exigencies on the part of the Investors / Company. We also wish to inform you that the copy of the Investor Presentation which shall be referred in the above mentioned meeting has already been uploaded on the website of the Company at www.metropolisindia.com and issued to the Stock Exchanges on May 24, 2022 The above is for the information of the Exchange and public at large.
17-06-2022

No plans to exit business, says Metropolis Healthcare promoters

"The company, its promoters and management team are committed to operating Metropolis Healthcare Ltd with the highest standards of medical science, stakeholder trust and customer engagement," the comp
14-06-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Media Statement

Please find attached, a Media statement issued by the Company. This will also be made available on Company's website www.metropolisindia.com. This is for your information and records.
13-06-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Submission Of Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions on a consolidated basis, prepared in accordance with applicable Accounting Standards for the half year ended March 31, 2022. The same will also be uploaded on the website of the Company at https://www.metropolisindia.com.
08-06-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir / Madam, Pursuant to the Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform that officials of the Company will be Meeting Investors (Participants) in the below conference: Date Conference Host Medium 7th & 8th June, 2022 Morgan Stanley Tele/Video Conferencing Kindly note that changes may happen due to exigencies on the part of the Investors / Company. We also wish to inform you that the copy of the Investor Presentation which shall be referred in the above mentioned meeting has already been uploaded on the website of the Company at www.metropolisindia.com and issued to the Stock Exchanges on May 24, 2022 The above is for the information of the Exchange and public at large.
06-06-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Intimation For Distribution Of Business Of Dr. Ganesan'S Hitech Diagnostic Centre Private Limited ('Hitech'), Subsidiary Of The Company

In continuation to our intimation dated April 01, 2022 having Reference No. MHL/Sec&Legal/2022-23/01, we wish to inform that the pursuant to the ongoing voluntary liquidation process, the liquidator of Hitech, has transferred the entire business undertaking of Hitech to the Company on a going concern basis on and with effect from 4th June 2022.
04-06-2022
Next Page
Close

Let's Open Free Demat Account